Riverain’s OnGuard Chest X-ray CAD is reportedly the only FDA PMA-approved chest X-ray CAD system. Working in conjunction with the reading of original standard AP/PA digital chest X-rays, OnGuard can quickly identify solitary pulmonary nodules that may be early stage lung cancer. It is designed to seamlessly integrate with any PACS workstation.
If you enjoy this content, please share it with a colleague
Related Content
April 9, 2024 — Mirion Dosimetry Services, a Mirion Medical company, today announced commercial availability of its ...
March 8, 2024 — DeepTek.ai, a leading medical imaging AI company, will showcase its groundbreaking US FDA-cleared chest ...
March 6, 2024 — Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced the successful validation ...
February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...
February 23, 2024 — Can dual-energy tomosynthesis be performed portably? This is one of the topics to be discussed by KA ...
February 6, 2024 — Medical imaging AI innovator, Qure.ai, has received breakthrough device designation from the Food and ...
February 2, 2024 — DeepTek.ai, a leading provider of artificial intelligence (AI) solutions for medical imaging ...
January 16, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced ...
January 16, 2024 — Nanox Imaging, an innovative medical imaging technology company, announced that the Company’s founder ...
January 15, 2024 — After fulfilling all regulatory requirements, the KA Imaging Premium Dual-Energy Mobile System ...